 | • レポートコード：MRC2012A0476 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、動脈瘤性くも膜下出血治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。動脈瘤性くも膜下出血治療薬の種類別市場規模（オピオイド鎮痛薬、カルシウムチャネル遮断薬、抗けいれん薬、便軟化剤、浸透圧剤、その他の薬剤）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Arbor Pharmaceuticals、Pharmaxis、Mylan N.V、PDS Biotechnology Corporation、Purdue Pharma、Johnson and Johnson、Teva Pharmaceutical、Pfizer、Orexo AB、Sun Pharmaceutical Industries、 ・地域別グローバル市場分析 2015年-2020年 ・動脈瘤性くも膜下出血治療薬の北米市場（アメリカ、カナダ、メキシコ） ・動脈瘤性くも膜下出血治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・動脈瘤性くも膜下出血治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・動脈瘤性くも膜下出血治療薬の南米市場（ブラジル、アルゼンチン） ・動脈瘤性くも膜下出血治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：オピオイド鎮痛薬、カルシウムチャネル遮断薬、抗けいれん薬、便軟化剤、浸透圧剤、その他の薬剤 ・用途別分析：病院、診療所、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Aneurysmal Subarachnoid Hemorrhage Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Aneurysmal Subarachnoid Hemorrhage Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.0%% in the forecast period of 2020 to 2025 and will expected to reach USD 168.9 million by 2025, from USD 156.3 million in 2019.
Market segmentation
Aneurysmal Subarachnoid Hemorrhage Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Aneurysmal Subarachnoid Hemorrhage Drugs market has been segmented into
Opioid Analgesic
Calcium Channel Blocker
Anticonvulsant
Stool Softener
Osmotic Agent
Other Drugs
By Application, Aneurysmal Subarachnoid Hemorrhage Drugs has been segmented into:
Hospital
Clinic
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Aneurysmal Subarachnoid Hemorrhage Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Aneurysmal Subarachnoid Hemorrhage Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Aneurysmal Subarachnoid Hemorrhage Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Aneurysmal Subarachnoid Hemorrhage Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Aneurysmal Subarachnoid Hemorrhage Drugs Market Share Analysis
Aneurysmal Subarachnoid Hemorrhage Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Aneurysmal Subarachnoid Hemorrhage Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Aneurysmal Subarachnoid Hemorrhage Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Aneurysmal Subarachnoid Hemorrhage Drugs are:
Arbor Pharmaceuticals
Pharmaxis
Mylan N.V
PDS Biotechnology Corporation
Purdue Pharma
Johnson and Johnson
Teva Pharmaceutical
Pfizer
Orexo AB
Sun Pharmaceutical Industries
Among other players domestic and global, Aneurysmal Subarachnoid Hemorrhage Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Aneurysmal Subarachnoid Hemorrhage Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Aneurysmal Subarachnoid Hemorrhage Drugs, with price, sales, revenue and global market share of Aneurysmal Subarachnoid Hemorrhage Drugs in 2018 and 2019.
Chapter 3, the Aneurysmal Subarachnoid Hemorrhage Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Aneurysmal Subarachnoid Hemorrhage Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Aneurysmal Subarachnoid Hemorrhage Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Aneurysmal Subarachnoid Hemorrhage Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Aneurysmal Subarachnoid Hemorrhage Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Opioid Analgesic
1.2.3 Calcium Channel Blocker
1.2.4 Anticonvulsant
1.2.5 Stool Softener
1.2.6 Osmotic Agent
1.2.7 Other Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Overview of Global Aneurysmal Subarachnoid Hemorrhage Drugs Market
1.4.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Arbor Pharmaceuticals
2.1.1 Arbor Pharmaceuticals Details
2.1.2 Arbor Pharmaceuticals Major Business
2.1.3 Arbor Pharmaceuticals SWOT Analysis
2.1.4 Arbor Pharmaceuticals Product and Services
2.1.5 Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pharmaxis
2.2.1 Pharmaxis Details
2.2.2 Pharmaxis Major Business
2.2.3 Pharmaxis SWOT Analysis
2.2.4 Pharmaxis Product and Services
2.2.5 Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Mylan N.V
2.3.1 Mylan N.V Details
2.3.2 Mylan N.V Major Business
2.3.3 Mylan N.V SWOT Analysis
2.3.4 Mylan N.V Product and Services
2.3.5 Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 PDS Biotechnology Corporation
2.4.1 PDS Biotechnology Corporation Details
2.4.2 PDS Biotechnology Corporation Major Business
2.4.3 PDS Biotechnology Corporation SWOT Analysis
2.4.4 PDS Biotechnology Corporation Product and Services
2.4.5 PDS Biotechnology Corporation Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Purdue Pharma
2.5.1 Purdue Pharma Details
2.5.2 Purdue Pharma Major Business
2.5.3 Purdue Pharma SWOT Analysis
2.5.4 Purdue Pharma Product and Services
2.5.5 Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Johnson and Johnson
2.6.1 Johnson and Johnson Details
2.6.2 Johnson and Johnson Major Business
2.6.3 Johnson and Johnson Product and Services
2.6.4 Johnson and Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Teva Pharmaceutical
2.7.1 Teva Pharmaceutical Details
2.7.2 Teva Pharmaceutical Major Business
2.7.3 Teva Pharmaceutical Product and Services
2.7.4 Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Product and Services
2.8.4 Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Orexo AB
2.9.1 Orexo AB Details
2.9.2 Orexo AB Major Business
2.9.3 Orexo AB Product and Services
2.9.4 Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sun Pharmaceutical Industries
2.10.1 Sun Pharmaceutical Industries Details
2.10.2 Sun Pharmaceutical Industries Major Business
2.10.3 Sun Pharmaceutical Industries Product and Services
2.10.4 Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Aneurysmal Subarachnoid Hemorrhage Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Aneurysmal Subarachnoid Hemorrhage Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020)
4.5 South America Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020)
6.3 UK Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020)
6.4 France Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020)
7.5 India Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Price by Type (2015-2020)
11 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Segment by Application
11.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Application (2015-2020)
11.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Aneurysmal Subarachnoid Hemorrhage Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Aneurysmal Subarachnoid Hemorrhage Drugs Market Forecast (2021-2025)
12.2.2 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Market Forecast (2021-2025)
12.2.4 South America Aneurysmal Subarachnoid Hemorrhage Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Drugs Market Forecast (2021-2025)
12.3 Aneurysmal Subarachnoid Hemorrhage Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Share Forecast by Type (2021-2025)
12.4 Aneurysmal Subarachnoid Hemorrhage Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Aneurysmal Subarachnoid Hemorrhage Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Arbor Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Major Business
Table 10. Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Total Revenue (USD Million) (2018-2019)
Table 11. Arbor Pharmaceuticals SWOT Analysis
Table 12. Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Product and Services
Table 13. Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Pharmaxis Basic Information, Manufacturing Base and Competitors
Table 15. Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Major Business
Table 16. Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Total Revenue (USD Million) (2018-2019)
Table 17. Pharmaxis SWOT Analysis
Table 18. Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Product and Services
Table 19. Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Mylan N.V Basic Information, Manufacturing Base and Competitors
Table 21. Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Major Business
Table 22. Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Total Revenue (USD Million) (2018-2019)
Table 23. Mylan N.V SWOT Analysis
Table 24. Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Product and Services
Table 25. Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. PDS Biotechnology Corporation Basic Information, Manufacturing Base and Competitors
Table 27. PDS Biotechnology Corporation Aneurysmal Subarachnoid Hemorrhage Drugs Major Business
Table 28. PDS Biotechnology Corporation Aneurysmal Subarachnoid Hemorrhage Drugs Total Revenue (USD Million) (2018-2019)
Table 29. PDS Biotechnology Corporation SWOT Analysis
Table 30. PDS Biotechnology Corporation Aneurysmal Subarachnoid Hemorrhage Drugs Product and Services
Table 31. PDS Biotechnology Corporation Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 33. Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Major Business
Table 34. Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Total Revenue (USD Million) (2018-2019)
Table 35. Purdue Pharma SWOT Analysis
Table 36. Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Product and Services
Table 37. Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 39. Johnson and Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Major Business
Table 40. Johnson and Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Total Revenue (USD Million) (2018-2019)
Table 41. Johnson and Johnson SWOT Analysis
Table 42. Johnson and Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Product and Services
Table 43. Johnson and Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 45. Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Major Business
Table 46. Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Total Revenue (USD Million) (2018-2019)
Table 47. Teva Pharmaceutical SWOT Analysis
Table 48. Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Product and Services
Table 49. Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Pfizer Basic Information, Manufacturing Base and Competitors
Table 51. Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Major Business
Table 52. Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Total Revenue (USD Million) (2018-2019)
Table 53. Pfizer SWOT Analysis
Table 54. Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Product and Services
Table 55. Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Orexo AB Basic Information, Manufacturing Base and Competitors
Table 57. Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Major Business
Table 58. Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Total Revenue (USD Million) (2018-2019)
Table 59. Orexo AB SWOT Analysis
Table 60. Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Product and Services
Table 61. Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 63. Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Major Business
Table 64. Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Total Revenue (USD Million) (2018-2019)
Table 65. Sun Pharmaceutical Industries SWOT Analysis
Table 66. Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Product and Services
Table 67. Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Manufacturer (2018-2019) (K MT)
Table 69. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 70. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Regions (2015-2020) (K MT)
Table 71. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Regions (2015-2020)
Table 72. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Regions (2015-2020) (USD Million)
Table 73. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Countries (2015-2020) (K MT)
Table 74. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Countries (2015-2020)
Table 75. North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Countries (2015-2020) (USD Million)
Table 76. North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Countries (2015-2020)
Table 77. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Countries (2015-2020) (K MT)
Table 78. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Countries (2015-2020)
Table 79. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Countries (2015-2020) (USD Million)
Table 80. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Regions (2015-2020) (K MT)
Table 81. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Regions (2015-2020)
Table 82. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Regions (2015-2020) (USD Million)
Table 83. South America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Countries (2015-2020) (K MT)
Table 84. South America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Countries (2015-2020)
Table 85. South America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Countries (2015-2020) (USD Million)
Table 86. South America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Countries (2015-2020)
Table 87. Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Countries (2015-2020) (K MT)
Table 88. Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Countries (2015-2020)
Table 89. Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Countries (2015-2020) (USD Million)
Table 90. Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Countries (2015-2020)
Table 91. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2015-2020) (K MT)
Table 92. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Type (2015-2020)
Table 93. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Type (2015-2020) (USD Million)
Table 94. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Type (2015-2020)
Table 95. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2015-2020) (K MT)
Table 96. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Application (2015-2020)
Table 97. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast by Regions (2021-2025) (K MT)
Table 98. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Share Forecast by Regions (2021-2025)
Table 99. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast by Type (2021-2025) (K MT)
Table 100. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Share Forecast by Type (2021-2025)
Table 101. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast by Application (2021-2025)
Table 102. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Share Forecast by Application (2021-2025)
Table 103. Direct Channel Pros & Cons
Table 104. Indirect Channel Pros & Cons
Table 105. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Aneurysmal Subarachnoid Hemorrhage Drugs Picture
Figure 2. Global Sales Market Share of Aneurysmal Subarachnoid Hemorrhage Drugs by Type in 2019
Figure 3. Opioid Analgesic Picture
Figure 4. Calcium Channel Blocker Picture
Figure 5. Anticonvulsant Picture
Figure 6. Stool Softener Picture
Figure 7. Osmotic Agent Picture
Figure 8. Other Drugs Picture
Figure 9. Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Application in 2019
Figure 10. Hospital Picture
Figure 11. Clinic Picture
Figure 12. Others Picture
Figure 13. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Manufacturer in 2019
Figure 34. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Aneurysmal Subarachnoid Hemorrhage Drugs Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Aneurysmal Subarachnoid Hemorrhage Drugs Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 39. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Regions (2015-2020)
Figure 41. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Regions in 2018
Figure 42. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020)
Figure 43. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020)
Figure 45. South America Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020)
Figure 47. North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Countries (2015-2020)
Figure 49. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Countries in 2018
Figure 50. North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Countries in 2018
Figure 52. United States Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 53. Canada Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 54. Mexico Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 55. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Countries in 2019
Figure 58. Germany Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 59. UK Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 60. France Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 61. Russia Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 62. Italy Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 63. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Regions 2019
Figure 66. China Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 67. Japan Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 68. Korea Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 69. India Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 70. Southeast Asia Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 71. South America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Countries in 2019
Figure 73. South America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Countries in 2019
Figure 74. Brazil Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 75. Argentina Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 76. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 81. Egypt Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 82. Turkey Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 83. South Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 84. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Growth Rate (2021-2025) (K MT)
Figure 85. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Aneurysmal Subarachnoid Hemorrhage Drugs Market Forecast (2021-2025) (K MT)
Figure 87. Europe Sales Aneurysmal Subarachnoid Hemorrhage Drugs Market Forecast (2021-2025) (K MT)
Figure 88. Asia-Pacific Sales Aneurysmal Subarachnoid Hemorrhage Drugs Market Forecast (2021-2025) (K MT)
Figure 89. South America Sales Aneurysmal Subarachnoid Hemorrhage Drugs Market Forecast (2021-2025) (K MT)
Figure 90. Middle East & Africa Sales Aneurysmal Subarachnoid Hemorrhage Drugs Market Forecast (2021-2025) (K MT)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
頭蓋内出血診断・治療の世界市場（～2026年） Bleeding or haemorrhages loss of blood from the circulatory system which may be internal or external due to variety of conditions such as trauma, tissue damage due to surgery, accidents, cuts etc. Generally loss of 10–15% of the total blood volume does not cause serious mental problems and can be to…- 分娩後異常出血（PPH）用治療装置の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Postpartum Hemorrhage (PPH) Treatment Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.0% in the forecast period of 2020 to 2025 and will expected to reach USD 713.7 million by 2025, from USD 610.5 million in 20…
- 産後出血治療装置の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Postpartum Hemorrhage Treatment Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Postp…
- オピオイド誘発性便秘（OIC）治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Opioid Induced Constipation (OIC) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Opioi…
- タイサブリ薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Tysabri Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tysabri Drugs market report pro…